DCGI allows Serum Institute to conduct phase II+III trials of Oxford University vaccine COVISHIELD for COVID-19
According to the Indian Council of Medical Research, the COVID-19 tests around India crossed a two-crore mark on Monday.
Full Article
DCGI allows Serum Institute to conduct phase II+III trials of Oxford University vaccine COVISHIELD for COVID-19
Zee News
0 shares
1 views
You might like
Related news coverage
COVID-19, Impacts And ASEAN Response: Pushing Back Vaccine Nationalism – Analysis
Eurasia Review
As ASEAN economic ministers meet virtually this week to deal with, among other things, the severe impacts of COVID-19, their..
-
Phase II trial of Oxford COVID-19 vaccine candidate to begin in PGI Chandigarh
Mid-Day
-
COVID-19 vaccine: Happy to be part of noble, global effort, says Pune trial volunteer
Mid-Day
-
Two Pune volunteers first to get trial dose of Covishield
IndiaTimes
-
Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin
Hindu
Advertisement
More coverage
Phase 2 trial of Oxford COVID-19 vaccine candidate to begin today
Mid-Day
The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India..